Skip to main content
Veterinary Medicines

Belacol 24 % Liquid

Authorised
  • COLISTIN SULFATE

Product identification

Medicine name:
Belacol 24 % Liquid
Belacol 24% liquid, 240 mg/ml, oplossing voor gebruik in drinkwater, melk of melkvervanger voor runderen, varkens en kippen
Active substance:
  • COLISTIN SULFATE
Target species:
  • Cattle (calf)
  • Pig
  • Chicken
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    240.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (calf)
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        1
        day
    • Chicken
      • Meat and offal
        1
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 5000 ml white PE plastic barrel with screw cap (PE)
  • 12 x 1000 ml white PE bottle with screw cap (with inlay) in a cardboard box
  • 1000 ml white PE bottle with screw cap (with inlay)
  • 1 x 250 ml white PE bottle with screw cap (with inlay) and dosing beaker in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 113900
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0181/001
Concerned member states:
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Portugal

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/01/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."